Status:
COMPLETED
Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
Lead Sponsor:
Shire
Conditions:
Kidney Failure, Chronic
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and to determine the...
Eligibility Criteria
Inclusion
- Patients with ESRD who currently require treatment for hyperphosphatemia
Exclusion
- Female patient who is pregnant or lactating
- Patient has used any investigational product within 30 days of screening
Key Trial Info
Start Date :
January 10 2005
Trial Type :
INTERVENTIONAL
End Date :
December 13 2005
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT00160121
Start Date
January 10 2005
End Date
December 13 2005
Last Update
July 2 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.